Cardiovascular Diseases Research in Maryland
Cardiovascular Diseases Research (93.837) awarded $467 million to recipients in Maryland in 415 grants from fiscal 2021 to 2025, 3.2% of the program's national total. The Johns Hopkins University received the most, $318 million.
- Awarded in Maryland$467 million
- Awards415
- Share of the program3.2%
- Rank among states9th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 192 | $87.1 million |
| FY 2022 | 188 | $92.7 million |
| FY 2023 | 203 | $97.1 million |
| FY 2024 | 207 | $96.9 million |
| FY 2025 | 193 | $93.4 million |
Recipients in Maryland
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Colleges and universities | 278 | $318 million |
| University of Maryland, Baltimore | Colleges and universities | 67 | $97.1 million |
| University of Maryland, College Park | Colleges and universities | 14 | $14.8 million |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Nonprofits | 7 | $5.3 million |
| Emocha Mobile Health Inc | Small businesses | 2 | $3.6 million |
| Kalocyte Inc | Small businesses | 2 | $3.5 million |
| Linshom Medical, Inc. | Small businesses | 2 | $3.0 million |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Nonprofits | 2 | $2.5 million |
| Pericor LLC | Small businesses | 2 | $2.1 million |
| Cartesian Therapeutics Inc | Small businesses | 1 | $2.0 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Maryland?
$467 million from fiscal 2021 to 2025, across 415 awards. Maryland ranks 9th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Maryland?
The largest recipient is The Johns Hopkins University, with $318 million in 278 awards. Next are University of Maryland, Baltimore and University of Maryland, College Park.
Can organizations in Maryland apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Maryland
- Grants to States for Medicaid
- Greenhouse Gas Reduction Fund: National Clean Investment Fund
- Education Stabilization Fund
- Highway Planning and Construction
- USAID Foreign Assistance for Programs Overseas
- 1332 State Innovation Waivers
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies